PP01.01: Oncogenic Signaling is Rewired to Support Nucleotide Metabolism in Acquired Resistance to Targeted Therapies in NSCLC
Back to course
Pdf Summary
Asset Subtitle
Jaime Schneider
Keywords
NSCLC
oncogenic signaling
nucleotide metabolism
tyrosine kinase inhibitors
GUK1
TKI resistance
c-MET
fusion-positive lung cancer
metabolic pathways
biomarkers
Powered By